Press ReleaseSource: Enzyme Environmental Solutions Inc.

Enzyme Environmental Solutions Completes Phase III Trials for Hazardous Waste Removal
Wednesday April 9, 2:00 pm ET

FORT WAYNE, IN--(MARKET WIRE)--Apr 9, 2008 -- Enzyme Environmental Solutions Inc. (Other OTC:EESO.PK - News) CEO Jared Hochstedler announced today that the company has recently completed Phase III trials to remove a portion of the hazardous waste created from the processing of scrap metals.

Hochstedler commented, "I am very pleased with the results of phase III and after seeing how well this product worked during the bench tests I feel confident that if this product performs as well during the prototype phase as it has during the bench studies, this product could be ready to go to market on a mass scale by the end of the year. There is an estimated $7.5 billion (USD) spent each year dealing with the hazardous waste."

Our testing has shown that by the use of our proprietary formulation the final waste can be broken down into environmentally friendly forms. The resulting product can actually be marketed for sale, thus transforming a huge expense into a new revenue stream for the scrap yard industry. It is estimated that in our hometown of Fort Wayne alone there is over $29 million (USD) per year spent on this problem," stated Hochstedler.

Hochstedler further commented, "If EESO is as successful in bringing this product to market, as I believe we will, EESO would have to adjust our company's revenue projections for next year. The potential of this revenue stream alone could ultimately be into the $100 million plus range. During phase IV, EESO will be interviewing and selecting a company with whom to partner in order to develop a working prototype. This will take an estimated 6-8 months to complete. Phase V will be the marketing stage. We are currently meeting with companies and discussing avenues to bring this product to market."

"I am thrilled to be working with such a talented development team. This is a very exciting product with several other large applications. For example: the cleaning of contaminated soils. We have started initial tests; however it is to early for any results. I really believe the EESO team has just discovered the tip of this iceberg. The company would also like to confirm that as of April 9, 2008 the outstanding share count remains at 223,716,398 common shares issued and outstanding," stated Hochstedler with a smile.

This press release contains certain "forward-looking" statements, as defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The Company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no factors that could cause actual results to differ materially from those estimated by the Company. They include, but are not limited to, the Company's ability to develop operations, the Company's ability to consummate and complete the acquisition, the Company's access to future capital, the successful integration of acquired companies, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, sales and other factors that may be identified from time to time in the Company's public announcements.


Contact:
     Contact:
     Enzyme Environmental Solutions, Inc.
     Jared Hochstedler
     President/CEO
     http://www.enzymeenvironmentalsolutions.com
     260-399-3837
      

Source: Enzyme Environmental Solutions Inc.


Mail to Friend Email Story
Alerts Set News Alert
Printer
Version  Print Story 


Copyright © 2008 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Copyright © 2008 Marketwire. All rights reserved. All the news releases provided by Marketwire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.